What Happened?
Waltham, MA-based Entasis Therapeutics Appointed Manos Perros as Chief Executive Officer
About the Company
Entasis Therapeutics is developing a portfolio of innovative cures for serious drug-resistant bacterial infections, a global health crisis affecting the lives of millions of patients. Our deep pipeline of novel clinical and preclinical antibacterial programs is designed to revolutionize the way physicians treat serious bacterial diseases.
About the Person
Manos Perros is Chief Executive Officer at Entasis Therapeutics. Previously, Manos held various senior HR leadership roles in the industry.
Info Source
News
Short Profile